At the completion of this activity, the participant will be able to:
1. Recognize the role of anticoagulation in ECMO and current guideline recommendations
2. Analyze the differences between heparin and bivalirudin
3. Compare literature describing the use of heparin and bivalirudin in ECMO patients
4.  Assess patient specific and cost considerations for selecting an anticoagulant in ECMO patients

Session date: 
10/26/2022 - 12:00pm to 1:00pm EDT
Location: 
AGH Magovern Auditorium and Zoom Meeting
To Join the Webinar: https://highmarkhealth.zoom.us/j/98672570454?pwd=VU80YWJYNjgraGVsQ0xkU2xSNWozQT09
Meeting ID: 986 7257 0454
Passcode: 877628
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Attendance

Please login or register to take this course.